Training: VO2max-training

Mandsager and colleagues analyzed 122,007 patients who underwent symptom-limited exercise treadmill testing at a single US health system between 1991 and 2014, with a mean age of 53 and a median follow-up of 8.4 years. Fitness was banded by age- and sex-specific performance: low (below the 25th percentile), below average, above average, high, and elite (above the 97.5th). Relative to the low group, adjusted all-cause mortality hazard ratios were 0.59 (below average), 0.41 (above average), 0.29 (high), and 0.20 (elite). The gradient continued into the elite band, so within this range no ceiling of benefit was seen. The adjusted risk of the low-fitness group exceeded that associated with coronary artery disease (HR 1.29), diabetes, and smoking in the same model.

Imboden and colleagues followed participants of the Ball State Adult Fitness Longitudinal Study whose VO2max was determined by direct gas-exchange analysis during a maximal treadmill test, the reference method, not a submaximal estimate. Over follow-up, higher measured fitness was associated with lower all-cause mortality in a graded fashion across the fitness spectrum, with the association holding in both men and women. Direct measurement matters because estimated fitness from treadmill time carries error that can inflate or blur the true relationship, and this cohort removes that source of noise.

Kodama and colleagues pooled 33 prospective cohort studies (all-cause mortality: 102,980 participants, 6,910 deaths; CHD/CVD events: 84,323 participants, 4,485 events) reporting maximal aerobic capacity in METs. A 1-MET increment carried a summary relative risk of 0.87 for all-cause mortality and 0.85 for CHD/CVD. Categorically, participants with low fitness (under about 7.9 METs) had a relative risk of 1.70 for all-cause mortality and 1.56 for CHD/CVD compared with high fitness (about 10.9 METs or more). One MET is roughly the difference a few weeks to months of aerobic training can produce, which is what makes the gradient actionable rather than merely descriptive.

Bacon and colleagues meta-analyzed controlled trials of high-intensity interval training and found a mean VO2max improvement of roughly 0.5 L/min. The largest and most consistent gains came from programs that used longer intervals near maximal aerobic effort, around three to five minutes each. The review also underlines that the average conceals a spread: some people gain far more and some far less from the same program, which the training-response literature examines directly.

Milanovic and colleagues meta-analyzed controlled trials pitting high-intensity interval training against moderate continuous endurance training for VO2max in adults. Both training styles produced significant improvements; the pooled difference modestly favored interval training, with a larger effect in less-fit participants and when the interval protocol used longer, harder bouts. Because the intervals concentrate the aerobic stimulus into brief hard efforts, the total exercise time to reach a given VO2max gain tends to be similar or shorter than with continuous training, which is the practical case for intervals, not a claim that steady cardio does not work.

Weston and colleagues meta-analyzed low-volume high-intensity interval training, defining it as short all-out efforts of 30 to 60 seconds; the typical protocol was four to six 30-second sprints, about two to three minutes of hard work per session. VO2max rose by a moderate amount, around 6% in active non-athletic men and about 10% in sedentary men, with smaller gains in women. The finding matters because time is the most common reason people give for not doing cardio: it establishes that the aerobic stimulus, not the total minutes, is what drives the adaptation, so brief sessions built around hard efforts are a legitimate dose, not a compromise.

This meta-analysis of randomized controlled trials in seniors aged 65 or over compared high-intensity interval training and continuous endurance training on peak oxygen uptake. Both improved peak VO2 significantly, and interval training yielded the greater gain, mirroring the pattern seen in younger adults. The clinical importance is direct: VO2max falls with age and a low value predicts loss of independence, so demonstrating that structured training reverses part of that decline in the over-65s makes it a lever, not an inevitability.

The Generation 100 study randomized 1,567 Norwegian adults born in 1936 to 1942 to five years of supervised high-intensity interval training (two 4x4 sessions a week), moderate continuous training, or a control group given national activity advice (which many followed). VO2max rose most in the interval group. The primary endpoint, all-cause mortality at five years, was 4.7% in controls, 5.9% in the moderate group, and 3.0% in the interval group; the difference did not reach statistical significance, in part because the control group also exercised and overall mortality was lower than expected. Read carefully, the trial shows structured training reliably raises fitness in the eighth decade of life and is safe at scale, while it was not large or long enough to prove a mortality benefit on its own.

Wisloff and colleagues randomized 27 patients with post-infarction heart failure to twelve weeks of aerobic interval training (4x4 minutes at 90 to 95% of peak heart rate) or isocaloric moderate continuous training. VO2peak rose about 46% with intervals versus about 14% with continuous training, and the interval group showed reverse left-ventricular remodeling and improved endothelial function. The trial is small and in a specific patient group, but it is a clean demonstration that the 4x4 stimulus drives large aerobic and cardiac adaptations even where capacity is severely limited, which is why the protocol carried over into general fitness use.

In the HERITAGE Family Study, healthy sedentary families completed the same fully standardized, supervised 20-week endurance training program. The gain in VO2max averaged about 0.4 L/min but ranged from near zero to more than 1 L/min. The response aggregated in families: the maximal heritability of the VO2max training response was about 47%, and between-family variance was roughly 2.5 times the within-family variance. This is the counterweight to the average-gain figures: training raises fitness for the group, but an individual can be a strong or a weak responder for reasons largely set before they start, which is a reason to judge a program by your own retest, not by the study mean.

Fleg and colleagues tracked peak VO2 by repeated maximal treadmill testing in 810 community-dwelling adults (435 men, 375 women) aged 21 to 87 in the Baltimore Longitudinal Study of Aging, over a median of 7.9 years. The longitudinal rate of decline was not constant: it accelerated from roughly 3 to 6% per 10 years in the third and fourth decades to more than 20% per 10 years in the seventh decade and beyond. From the 40s onward the per-decade decline was larger in men than in women. Similar relative rates of decline held across all quartiles of self-reported leisure-time physical activity, so an active life was associated with a higher absolute peak VO2, not a gentler slope. That reframes the practical goal of training in later life: not stopping the age-related fall, but staying on a higher line, so a given level of capacity is reached years later.

The FRIEND registry (Fitness Registry and the Importance of Exercise National Database) pooled directly measured maximal cardiopulmonary exercise tests to build reference percentiles for VO2max by age and sex. The standards show the expected decline in maximal capacity across decades and the average difference between men and women, allowing a measured or well-estimated value to be expressed as a percentile, not a bare figure. For a reader, this is the missing half of a measurement: the number matters only relative to peers, and moving up percentile bands is a more meaningful goal than hitting one absolute value.